The Female Infertility Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Female Infertility Market?
The market size of the female infertility sector has been experiencing consistent growth. It is projected to rise from $1.79 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Female Infertility Industry?
The Female Infertility Global Market Report 2025 predicts that by 2029, the market size will be $2.19 billion, growing at a compound annual growth rate (CAGR) of 4.1%.
Download Your Free Sample of the 2025 Female Infertility Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Female Infertility Market?
The key drivers in the female infertility market are:
•Rising awareness of fertility issues
•Increasing cases of polycystic ovary syndrome
•Rising incidence of genetic disorders, including uterine abnormalities
•Increase in obesity-related infertility cases
Global Market Segmentation: Identifying Major Female Infertility Industry Segments
The female infertility market covered in this report is segmented –
1) By Treatment: Clomiphene Citrate, Gonadotropins, Metformin, Letrozole, Bromocriptine
2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
3) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Clomiphene Citrate: Oral Clomiphene Citrate, Injectable Clomiphene Citrate
2) By Gonadotropins: Recombinant Gonadotropins, Urinary Gonadotropins, Human Chorionic Gonadotropin (hCG)
3) By Metformin: Immediate-Release Metformin, Extended-Release Metformin
4) By Letrozole: Oral Letrozole Tablets, Injectable Letrozole
5) By Bromocriptine: Oral Bromocriptine Tablets, Intranasal Bromocriptine
Pre-order the 2025 Female Infertility Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Female Infertility Market?
The key trends in the female infertility market are:
•Technological advancement and novel diagnostic technologies are emerging trends in the market.
•Preimplantation genetic testing is gaining popularity.
•The need for fertility preservation methods is increasing.
•Telemedicine applications in the treatment of female infertility are evolving.
Who Are the Top Competitors & Leading Players in the Female Infertility Market?
Major players in the female infertility market are:
• Pfizer Inc.
• Roche Holding AG
• Merck And Co. Inc
• Bayer AG
• Sanofi S.A.
• AstraZeneca Plc
• Abbott Laboratories
• Mayo Clinic
• Teva Pharmaceutical Industries Ltd
• Commonwealth Serum Laboratories Ltd
• Organon Theramex
• Juniper Reproductive Health Ltd.
• Sumitomo Pharma
• Ferring Pharmaceuticals
• Livzon Pharmaceutical Group Co.
• Mankind Pharma
• Kissei Pharmaceutical Co Ltd
• ASKA Pharmaceutical Co. Ltd.
• Fuji Pharma Co. Ltd.
• ARMC IVF
• Zydus Cadila Healthcare
• IBSA Institut Biochimique
• Oxolife
• Ava AG
• Hernova Lifesciences Holdings Ltd
Regional Dominance: Which Area Leads the Global Template Market?
Europe was the largest region in the female infertility market in 2024
